Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_ |
Author(s) : Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD |
Ref : J Am Heart Assoc , 5 : , 2016 |
Abstract : Wallentin_2016_J.Am.Heart.Assoc_5_ |
ESTHER : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedID: 27329448 |
Title : Genetic determinants of dabigatran plasma levels and their relation to bleeding - Pare_2013_Circulation_127_1404 |
Author(s) : Pare G , Eriksson N , Lehr T , Connolly S , Eikelboom J , Ezekowitz MD , Axelsson T , Haertter S , Oldgren J , Reilly P , Siegbahn A , Syvanen AC , Wadelius C , Wadelius M , Zimdahl-Gelling H , Yusuf S , Wallentin L |
Ref : Circulation , 127 :1404 , 2013 |
Abstract : Pare_2013_Circulation_127_1404 |
ESTHER : Pare_2013_Circulation_127_1404 |
PubMedSearch : Pare_2013_Circulation_127_1404 |
PubMedID: 23467860 |